January 19, 2017 5:20 AM ET


Company Overview of Agios Pharmaceuticals, Inc.

Key Executives for Agios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David P. Schenkein M.D.56 RelationshipsChief Executive Officer, President and Director59
Lewis Clayton Cantley Ph.D.70 RelationshipsCo-Founder, Director and Member of Scientific Advisory Board67
Tak Wah Mak Ph.D., D.Sc., FRSC155 RelationshipsCo-Founder and Member of Scientific Advisory Board70
Shin-San Su Ph.D.16 RelationshipsCo-Founder and Member of Scientific Advisory Board60
Craig B. Thompson M.D.132 RelationshipsCo-Founder and Chairman of Scientific Advisory Board63
View More Key Executives

Agios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John M. Maraganore M.D., Ph.D. 169 RelationshipsAlnylam Pharmaceuticals, Inc.53
David P. Schenkein M.D. 56 RelationshipsAgios Pharmaceuticals, Inc.59
Lewis Clayton Cantley Ph.D. 70 RelationshipsAgios Pharmaceuticals, Inc.67
Tak Wah Mak Ph.D., D.Sc., FRSC 155 RelationshipsAgios Pharmaceuticals, Inc.70
Craig B. Thompson M.D. 132 RelationshipsAgios Pharmaceuticals, Inc.63
View All Board Members

Agios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee M.B.A.Paul J. Clancy22 Relationships2 Executives
Compensation Committee Kaye I. Foster-Cheek40 Relationships3 Executives
Nominating Committee Kaye I. Foster-Cheek40 Relationships2 Executives
Corporate Governance Committee Kaye I. Foster-Cheek40 Relationships2 Executives
Advisory Board M.D.Craig B. Thompson132 Relationships10 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$54.6M
Not meaningful
Total Value of Options$517.5K
Compensation as of Fiscal Year 2015
Agios Pharmaceuticals, Inc. CEO Compensation
Industry Average


OptiBiotix Health plc Appoints Christina Wood as Sales and Marketing Director
January 18, 2017 7:00 AM ET
Galapagos NV Appoints Walid Abi-Saab as Chief Medical Officer, Beginning on 1 March 2017
January 17, 2017 9:05 PM ET
EMD Serono Announces Executive Changes
January 17, 2017 2:00 PM ET
Cleave Biosciences Promotes Kanya Rajangam to Chief Medical Officer
January 17, 2017 1:28 PM ET
Bicycle Therapeutics Appoints Nicholas Keen as Chief Scientific Officer
January 17, 2017 1:22 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Agios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.